Global Breast Cancer Therapeutics Market to Focus on Developing Companion Diagnostics Models, Reports TMR
Request Free Sample of Research Report: http://bit.ly/2cEkyg8
Mergers and acquisitions will also shape the trajectory of progress for the players in the overall market. For instance, Novartis took over the oncology drug segment of GlaxoSmithKline in 2015, which will help the company add another 22 drugs including Tykerb to its pipeline.
The lead author of this research report says, “New product launches and investments in clinical testing and trials are also expected to work in the favor of drug breast cancer therapeutics companies to diversify their portfolio and win bigger shares.”
Increased Breast Cancer Risk to Pave Way for Steady Consumption of Breast Cancer Therapeutics
The increasing risk of breast cancer amongst women due to early onset of menopause, growing pool of geriatric women, and lifestyle changes are some of the factors driving the breast cancer therapeutics market. The changes in delayed childbearing, reproductive patterns, reduced breast feeding, excessive intake of oral contraceptive pills, and other estrogen modifying drug therapies are also contributing to the increasing risks of breast cancer amongst women.
The growing problem of obesity is also considered to be a major factor contributing towards rising cases of breast cancer. The fat tissues are known to be major producers of estrogen amongst postmenopausal women. Thus, excess fat and the high prevalence of obesity is indirectly driving the global breast cancer therapeutics market.
The growth of domestic pharmaceutical companies that are making investments to meet the unmet demands of patients by manufacturing generic drugs as several patented drugs reach their patient expiration date are expected to boost the market. Furthermore, this market is also expected to find opportunity in developing companion diagnostic models that are customized for specific patients in accordance with the molecular characteristics of their malignancy.
Entry of Local Manufacturers Could Eat into Revenues of Branded Drugs
However, the entry of local drug manufacturers has intensified the competition in the breast cancer therapeutics market. These manufacturers are offering generic versions of breast cancer drugs, which is severely impacting the market for branded drugs. The exorbitant cost of surgeries, radiation therapy, and chemotherapy also makes it unaffordable for a large number of patients, especially in the developing regions, where healthcare infrastructure is poor. All of these factors are expected to hamper the growth of the breast cancer therapeutics market in the foreseeable future.
Patent Expiry Drives HER2 Inhibitors Segment as Generic Drugs will Become Affordable
Currently, North America holds a sizeable share in the global breast cancer therapeutics market due to supportive insurance schemes. In the coming years, this regional segment will acquire a 36.2% share of the overall market revenue. The significant drug segment in the market will be HER2 inhibitors in the forecast period as patents near expiration dates, giving entry to generic drugs.
Browse Research Report: http://bit.ly/1L0NYzX
Thus, this drug segment will expand at a CAGR of 6.2% between 2015 and 2023. Given these positive developments, the opportunity in the overall market is also expected to rise to US$16.21 bn by 2023 from US$7.17 bn in 2014, enabling the market to exhibit a CAGR of 8.4% between 2015 and 2023.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Breast Cancer Therapeutics Market to Focus on Developing Companion Diagnostics Models, Reports TMR here
News-ID: 361398 • Views: 468
More Releases from Transparency Market Research - Pharmaceutical
Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Global Neurovascular Devices Market: Overview The global population is aging rapidly. According to WHO, the chances of health risks are greater in geriatric people than the young generation. Old age is considered to be one of the biggest risk factors that are responsible for developing various diseases such as cardiovascular and neurological conditions. It is because of these factors, the global neurovascular devices market is experiencing robust growth in the
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2 …
Transparency Market Research (TMR) has published a new report titled, “Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pneumococcal vaccines market was valued at US$ 7,247.6 Mn in 2017 and is anticipated expand at a CAGR of 3.3% from 2018 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, rise
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from …
Swab and Viral Transport Medium Market: Introduction Transparency Market Research has published a new report titled, ‘Global Swab and Viral Transport Medium Market ’. According to the report, the global swab and viral transport medium market was valued at US$ 0.9 Bn in 2019 and is projected to expand at a CAGR of ~3% from 2020 to 2030. Viral transport medium (VTM) enables safe transfer of viruses, chlamydia, and mycoplasma for
Radiofrequency Ablation Devices Market by Product, Geography and Forecast to 202 …
Transparency Market Research (TMR) has published a new report titled, 'Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027. Overview Radiofrequency ablation is a minimally invasive surgical
More Releases for TMR
Tumblers Market 2028 | TMR Research
The tumblers market is expected to set growth straight with rising demand for new attractive designs for liquors including alcoholic, and non-alcoholic in emerging region of Asia pacific. The rising disposable income, increasing access to quality products, and new product launches customised to suit the taste of the region promise major growth for the tumblers market in near future. Download Brochure of This Market Report at - https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6200 Among regions, North America,
Global 3D Animation Market: Snapshot The evolution and introduction of three-dimensional (3D) animation has given the world of animation a new perspective. The process of creating 3D moving images in a digital space through objects or models has given these illusions depth. One of the most fundamental differences between 2D animation and 3D animation is the technique used for creating the images and the way they look. The global 3D animation
Various strategies are leveraged by success-hungry players in the global hyperbaric oxygen therapy devices market. One of them is the thrust on research and development to come up with new or better products. Their focus is on building cost-effective medical devices that would see greater uptake. Strategic partnerships are also being undertaken by them to diversify product portfolios and gain greater share. Further, companies are shifting their gaze to developing
Monolithic Ceramics Market Analysis : TMR
Transparency Market Research has published a new market report titled “Monolithic Ceramics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023.” According to the report, the global monolithic ceramics market was valued at US$ 19.43 Bn in 2014 and is anticipated to reach US$ 36.64 Bn by 2023, expanding at a CAGR of 7.3% between 2015 and 2023. Request to view Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3158 Monolithic ceramics are
Wax Market Analysis : TMR
A recent research report published by Transparency Market Research projects the global wax market to expand at a CAGR of 2.6% during the period between 2014 and 2020. The report, titled “Wax Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020,” estimates the global wax market to be worth US$8.98 bn by 2020. The overall market stood at a valuation of US$8.21 bn in 2013
Sulfone Polymers Market Analysis : TMR
Global Sulfone Polymers Market: Snapshot Several grades/varieties of sulfone polymers have gained vast applicability across a number of industries in the past few years. The relatively higher level of resistance wear and corrosion provided by these materials as compared to metals have increased their usage in medical devices and implants. Owing to their high transparency resistance, low weight, and high performance, the demand for sulfone polymers is also rising in the